{"id":"https://openalex.org/W2129373115","doi":"https://doi.org/10.1111/j.1476-5381.2012.01942.x","title":"Pharmacological properties of S1RA, a new sigma\u20101 receptor antagonist that inhibits neuropathic pain and activity\u2010induced spinal sensitization","display_name":"Pharmacological properties of S1RA, a new sigma\u20101 receptor antagonist that inhibits neuropathic pain and activity\u2010induced spinal sensitization","publication_year":2012,"publication_date":"2012-03-09","ids":{"openalex":"https://openalex.org/W2129373115","doi":"https://doi.org/10.1111/j.1476-5381.2012.01942.x","mag":"2129373115","pmid":"https://pubmed.ncbi.nlm.nih.gov/22404321","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3448894"},"language":"en","primary_location":{"id":"doi:10.1111/j.1476-5381.2012.01942.x","doi":"https://doi.org/10.1111/j.1476-5381.2012.01942.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.2012.01942.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.2012.01942.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.2012.01942.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058061813","display_name":"Luz I. Romero","orcid":"https://orcid.org/0000-0002-4148-1889","observed_orcids":["https://orcid.org/0000-0002-4148-1889"]},"institutions":[{"id":"https://openalex.org/I4210162160","display_name":"Esteve (Spain)","ror":"https://ror.org/04yns5a36","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210162160"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"L Romero","raw_affiliation_strings":["Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain","institution_ids":["https://openalex.org/I4210162160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026686227","display_name":"Daniel Zamanillo","orcid":"https://orcid.org/0000-0002-1032-6093","observed_orcids":["https://orcid.org/0000-0002-1032-6093"]},"institutions":[{"id":"https://openalex.org/I4210162160","display_name":"Esteve (Spain)","ror":"https://ror.org/04yns5a36","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210162160"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"D Zamanillo","raw_affiliation_strings":["Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain","institution_ids":["https://openalex.org/I4210162160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060645327","display_name":"Xavier Nadal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170486558","display_name":"Universitat Pompeu Fabra","ror":"https://ror.org/04n0g0b29","country_code":"ES","type":"education","lineage":["https://openalex.org/I170486558"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"X Nadal","raw_affiliation_strings":["Laboratory of Neuropharmacology, Facultat de Cie\u0300ncies de la Salut i de la Vida, Universitat Pompeu Fabra, Barcelona, Spain","Laboratory of Neuropharmacology, Facultat de Ci\u00e8ncies de la Salut i de la Vida, Universitat Pompeu Fabra, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Neuropharmacology, Facultat de Cie\u0300ncies de la Salut i de la Vida, Universitat Pompeu Fabra, Barcelona, Spain","institution_ids":["https://openalex.org/I170486558"]},{"raw_affiliation_string":"Laboratory of Neuropharmacology, Facultat de Ci\u00e8ncies de la Salut i de la Vida, Universitat Pompeu Fabra, Barcelona, Spain","institution_ids":["https://openalex.org/I170486558"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111820118","display_name":"Ricard S\u00e1nchez-Arroyos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162160","display_name":"Esteve (Spain)","ror":"https://ror.org/04yns5a36","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210162160"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"R S\u00e1nchez\u2010Arroyos","raw_affiliation_strings":["Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain","institution_ids":["https://openalex.org/I4210162160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072170978","display_name":"Ivan Rivera\u2010Arconada","orcid":"https://orcid.org/0000-0002-9845-6625","observed_orcids":["https://orcid.org/0000-0002-9845-6625"]},"institutions":[{"id":"https://openalex.org/I189268942","display_name":"Universidad de Alcal\u00e1","ror":"https://ror.org/04pmn0e78","country_code":"ES","type":"education","lineage":["https://openalex.org/I189268942"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"I Rivera\u2010Arconada","raw_affiliation_strings":["Department of Physiology, Faculty of Medicine, Universidad de Alcala\u0301 de Henares. Alcala\u0301 de Henares, Spain","Department of Physiology, Faculty of Medicine, Universidad de Alcal\u00e1 de Henares. Alcal\u00e1 de Henares, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physiology, Faculty of Medicine, Universidad de Alcala\u0301 de Henares. Alcala\u0301 de Henares, Spain","institution_ids":["https://openalex.org/I189268942"]},{"raw_affiliation_string":"Department of Physiology, Faculty of Medicine, Universidad de Alcal\u00e1 de Henares. Alcal\u00e1 de Henares, Spain","institution_ids":["https://openalex.org/I189268942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007105595","display_name":"Albert Dordal","orcid":"https://orcid.org/0000-0003-2869-9506","observed_orcids":["https://orcid.org/0000-0003-2869-9506"]},"institutions":[{"id":"https://openalex.org/I4210162160","display_name":"Esteve (Spain)","ror":"https://ror.org/04yns5a36","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210162160"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"A Dordal","raw_affiliation_strings":["Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain","institution_ids":["https://openalex.org/I4210162160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101991624","display_name":"Ana Montero","orcid":"https://orcid.org/0000-0002-0861-351X","observed_orcids":["https://orcid.org/0000-0002-0861-351X"]},"institutions":[{"id":"https://openalex.org/I4210162160","display_name":"Esteve (Spain)","ror":"https://ror.org/04yns5a36","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210162160"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"A Montero","raw_affiliation_strings":["Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain","institution_ids":["https://openalex.org/I4210162160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111930772","display_name":"Anna Muro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162160","display_name":"Esteve (Spain)","ror":"https://ror.org/04yns5a36","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210162160"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"A Muro","raw_affiliation_strings":["Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain","institution_ids":["https://openalex.org/I4210162160"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A Bura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170486558","display_name":"Universitat Pompeu Fabra","ror":"https://ror.org/04n0g0b29","country_code":"ES","type":"education","lineage":["https://openalex.org/I170486558"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"A Bura","raw_affiliation_strings":["Laboratory of Neuropharmacology, Facultat de Cie\u0300ncies de la Salut i de la Vida, Universitat Pompeu Fabra, Barcelona, Spain","Laboratory of Neuropharmacology, Facultat de Ci\u00e8ncies de la Salut i de la Vida, Universitat Pompeu Fabra, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Neuropharmacology, Facultat de Cie\u0300ncies de la Salut i de la Vida, Universitat Pompeu Fabra, Barcelona, Spain","institution_ids":["https://openalex.org/I170486558"]},{"raw_affiliation_string":"Laboratory of Neuropharmacology, Facultat de Ci\u00e8ncies de la Salut i de la Vida, Universitat Pompeu Fabra, Barcelona, Spain","institution_ids":["https://openalex.org/I170486558"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058551484","display_name":"C. Segal\u00e9s","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162160","display_name":"Esteve (Spain)","ror":"https://ror.org/04yns5a36","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210162160"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"C Segal\u00e9s","raw_affiliation_strings":["Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain","institution_ids":["https://openalex.org/I4210162160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089837532","display_name":"M. Laloya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162160","display_name":"Esteve (Spain)","ror":"https://ror.org/04yns5a36","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210162160"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M Laloya","raw_affiliation_strings":["Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain","institution_ids":["https://openalex.org/I4210162160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023696952","display_name":"Enrique Hern\u00e1ndez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162160","display_name":"Esteve (Spain)","ror":"https://ror.org/04yns5a36","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210162160"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"E Hern\u00e1ndez","raw_affiliation_strings":["Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain","institution_ids":["https://openalex.org/I4210162160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041539830","display_name":"Enrique F. Portillo-Salido","orcid":"https://orcid.org/0000-0002-4585-3715","observed_orcids":["https://orcid.org/0000-0002-4585-3715"]},"institutions":[{"id":"https://openalex.org/I4210162160","display_name":"Esteve (Spain)","ror":"https://ror.org/04yns5a36","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210162160"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"E Portillo\u2010Salido","raw_affiliation_strings":["Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain","institution_ids":["https://openalex.org/I4210162160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008984659","display_name":"Marisol Escriche","orcid":"https://orcid.org/0000-0002-4735-424X","observed_orcids":["https://orcid.org/0000-0002-4735-424X"]},"institutions":[{"id":"https://openalex.org/I4210162160","display_name":"Esteve (Spain)","ror":"https://ror.org/04yns5a36","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210162160"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M Escriche","raw_affiliation_strings":["Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain","institution_ids":["https://openalex.org/I4210162160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091728921","display_name":"Xavier Codony","orcid":"https://orcid.org/0000-0002-8921-6902","observed_orcids":["https://orcid.org/0000-0002-8921-6902"]},"institutions":[{"id":"https://openalex.org/I4210162160","display_name":"Esteve (Spain)","ror":"https://ror.org/04yns5a36","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210162160"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"X Codony","raw_affiliation_strings":["Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain","institution_ids":["https://openalex.org/I4210162160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044374548","display_name":"Gregorio Encina","orcid":"https://orcid.org/0000-0001-5953-8911","observed_orcids":["https://orcid.org/0000-0001-5953-8911"]},"institutions":[{"id":"https://openalex.org/I4210162160","display_name":"Esteve (Spain)","ror":"https://ror.org/04yns5a36","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210162160"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"G Encina","raw_affiliation_strings":["Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain","institution_ids":["https://openalex.org/I4210162160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079313086","display_name":"Javier Burgue\u00f1o","orcid":"https://orcid.org/0000-0001-8938-8299","observed_orcids":["https://orcid.org/0000-0001-8938-8299"]},"institutions":[{"id":"https://openalex.org/I4210162160","display_name":"Esteve (Spain)","ror":"https://ror.org/04yns5a36","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210162160"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"J Burgue\u00f1o","raw_affiliation_strings":["Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain","institution_ids":["https://openalex.org/I4210162160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048779913","display_name":"Manuel Merlos","orcid":"https://orcid.org/0000-0002-8423-3033","observed_orcids":["https://orcid.org/0000-0002-8423-3033"]},"institutions":[{"id":"https://openalex.org/I4210162160","display_name":"Esteve (Spain)","ror":"https://ror.org/04yns5a36","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210162160"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M Merlos","raw_affiliation_strings":["Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain","institution_ids":["https://openalex.org/I4210162160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000200160","display_name":"Jose Manuel Baeyens","orcid":"https://orcid.org/0000-0001-7168-0523","observed_orcids":["https://orcid.org/0000-0001-7168-0523"]},"institutions":[{"id":"https://openalex.org/I173304897","display_name":"Universidad de Granada","ror":"https://ror.org/04njjy449","country_code":"ES","type":"education","lineage":["https://openalex.org/I173304897"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"JM Baeyens","raw_affiliation_strings":["Department of Pharmacology and Institute of Neuroscience, Faculty of Medicine, Universidad de Granada, Granada, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Institute of Neuroscience, Faculty of Medicine, Universidad de Granada, Granada, Spain","institution_ids":["https://openalex.org/I173304897"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088909083","display_name":"Jes\u00fas Giraldo","orcid":"https://orcid.org/0000-0001-7082-4695","observed_orcids":["https://orcid.org/0000-0001-7082-4695","https://orcid.org/0000-0002-0477-472X"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"J Giraldo","raw_affiliation_strings":["Laboratory of Systems Pharmacology and Bioinformatics, Institut de Neurocie\u0300ncies and Unitat de Bioestadi\u0301stica, Universitat Auto\u0300noma de Barcelona, Bellaterra, Spain","Laboratory of Systems Pharmacology and Bioinformatics, Institut de Neuroci\u00e8ncies and Unitat de Bioestad\u00edstica, Universitat Aut\u00f2noma de Barcelona, Bellaterra, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Systems Pharmacology and Bioinformatics, Institut de Neurocie\u0300ncies and Unitat de Bioestadi\u0301stica, Universitat Auto\u0300noma de Barcelona, Bellaterra, Spain","institution_ids":["https://openalex.org/I123044942"]},{"raw_affiliation_string":"Laboratory of Systems Pharmacology and Bioinformatics, Institut de Neuroci\u00e8ncies and Unitat de Bioestad\u00edstica, Universitat Aut\u00f2noma de Barcelona, Bellaterra, Spain","institution_ids":["https://openalex.org/I123044942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067264104","display_name":"Jose Antonio Lopez-Garcia","orcid":"https://orcid.org/0000-0002-1725-6665","observed_orcids":["https://orcid.org/0000-0002-1725-6665"]},"institutions":[{"id":"https://openalex.org/I189268942","display_name":"Universidad de Alcal\u00e1","ror":"https://ror.org/04pmn0e78","country_code":"ES","type":"education","lineage":["https://openalex.org/I189268942"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"JA L\u00f3pez\u2010Garc\u00eda","raw_affiliation_strings":["Department of Physiology, Faculty of Medicine, Universidad de Alcala\u0301 de Henares. Alcala\u0301 de Henares, Spain","Department of Physiology, Faculty of Medicine, Universidad de Alcal\u00e1 de Henares. Alcal\u00e1 de Henares, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physiology, Faculty of Medicine, Universidad de Alcala\u0301 de Henares. Alcala\u0301 de Henares, Spain","institution_ids":["https://openalex.org/I189268942"]},{"raw_affiliation_string":"Department of Physiology, Faculty of Medicine, Universidad de Alcal\u00e1 de Henares. Alcal\u00e1 de Henares, Spain","institution_ids":["https://openalex.org/I189268942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037897982","display_name":"Rafael J. Maldonado","orcid":"https://orcid.org/0000-0002-4359-8773","observed_orcids":["https://orcid.org/0000-0002-4359-8773","https://orcid.org/0000-0002-1000-8378","https://orcid.org/0000-0001-8628-5219"]},"institutions":[{"id":"https://openalex.org/I170486558","display_name":"Universitat Pompeu Fabra","ror":"https://ror.org/04n0g0b29","country_code":"ES","type":"education","lineage":["https://openalex.org/I170486558"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"R Maldonado","raw_affiliation_strings":["Laboratory of Neuropharmacology, Facultat de Cie\u0300ncies de la Salut i de la Vida, Universitat Pompeu Fabra, Barcelona, Spain","Laboratory of Neuropharmacology, Facultat de Ci\u00e8ncies de la Salut i de la Vida, Universitat Pompeu Fabra, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Neuropharmacology, Facultat de Cie\u0300ncies de la Salut i de la Vida, Universitat Pompeu Fabra, Barcelona, Spain","institution_ids":["https://openalex.org/I170486558"]},{"raw_affiliation_string":"Laboratory of Neuropharmacology, Facultat de Ci\u00e8ncies de la Salut i de la Vida, Universitat Pompeu Fabra, Barcelona, Spain","institution_ids":["https://openalex.org/I170486558"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084304065","display_name":"Carlos R. Plata\u2010Sal\u00e1man","orcid":"https://orcid.org/0000-0002-8258-7671","observed_orcids":["https://orcid.org/0000-0002-8258-7671"]},"institutions":[{"id":"https://openalex.org/I4210162160","display_name":"Esteve (Spain)","ror":"https://ror.org/04yns5a36","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210162160"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"CR Plata\u2010Salam\u00e1n","raw_affiliation_strings":["Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain","institution_ids":["https://openalex.org/I4210162160"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024404946","display_name":"Jos\u00e9 Miguel Vela","orcid":"https://orcid.org/0000-0002-6809-1477","observed_orcids":["https://orcid.org/0000-0002-6809-1477"]},"institutions":[{"id":"https://openalex.org/I4210162160","display_name":"Esteve (Spain)","ror":"https://ror.org/04yns5a36","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210162160"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"JM Vela","raw_affiliation_strings":["Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Esteve, Drug Discovery and Preclinical Development, Barcelona, Spain","institution_ids":["https://openalex.org/I4210162160"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5024404946"],"corresponding_institution_ids":["https://openalex.org/I4210162160"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":10.5925,"has_fulltext":true,"cited_by_count":187,"citation_normalized_percentile":{"value":0.99567474,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"166","issue":"8","first_page":"2289","last_page":"2306"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.6934000253677368,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.6934000253677368,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.30469998717308044,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11840","display_name":"Pain Management and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sigma-1-receptor","display_name":"sigma-1 receptor","score":0.9610000252723694},{"id":"https://openalex.org/keywords/sigma-1-receptor-antagonists","display_name":"sigma-1 receptor antagonists","score":0.9039999842643738},{"id":"https://openalex.org/keywords/neuropathic-pain","display_name":"neuropathic pain","score":0.9959999918937683},{"id":"https://openalex.org/keywords/spinal-sensitization","display_name":"spinal sensitization","score":0.8209999799728394},{"id":"https://openalex.org/keywords/central-sensitization","display_name":"central sensitization","score":0.9319999814033508},{"id":"https://openalex.org/keywords/formalin-induced-nociception","display_name":"formalin-induced nociception","score":0.8230000138282776},{"id":"https://openalex.org/keywords/sciatic-nerve-injury","display_name":"sciatic nerve injury","score":0.9800000190734863},{"id":"https://openalex.org/keywords/wind-up","display_name":"wind-up","score":0.5649999976158142},{"id":"https://openalex.org/keywords/antihyperalgesic-effect","display_name":"antihyperalgesia","score":0.6639999747276306},{"id":"https://openalex.org/keywords/receptor-occupancy","display_name":"receptor occupancy","score":0.8019999861717224}],"concepts":[{"id":"https://openalex.org/C2777107010","wikidata":"https://www.wikidata.org/wiki/Q2798704","display_name":"Neuropathic pain","level":2,"score":0.7328273057937622},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7191251516342163},{"id":"https://openalex.org/C103133801","wikidata":"https://www.wikidata.org/wiki/Q408572","display_name":"Sigma-1 receptor","level":4,"score":0.6685211062431335},{"id":"https://openalex.org/C15490471","wikidata":"https://www.wikidata.org/wiki/Q2734305","display_name":"Nociception","level":3,"score":0.6635959148406982},{"id":"https://openalex.org/C2776217527","wikidata":"https://www.wikidata.org/wiki/Q944828","display_name":"Sensitization","level":2,"score":0.5940375924110413},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5682669878005981},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5230320692062378},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4711804687976837},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.4488258957862854},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3327816128730774},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.1447400152683258},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14403018355369568},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1421516239643097},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.09909817576408386}],"mesh":[{"descriptor_ui":"D000097605","descriptor_name":"Sigma-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000700","descriptor_name":"Analgesics","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002211","descriptor_name":"Capsaicin","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D004558","descriptor_name":"Electric Stimulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005557","descriptor_name":"Formaldehyde","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D005786","descriptor_name":"Gene Expression Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005786","descriptor_name":"Gene Expression Regulation","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009437","descriptor_name":"Neuralgia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010147","descriptor_name":"Pain Measurement","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017480","descriptor_name":"Receptors, sigma","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/j.1476-5381.2012.01942.x","doi":"https://doi.org/10.1111/j.1476-5381.2012.01942.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.2012.01942.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.2012.01942.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3481866","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3448894","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3448894","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3448894","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},{"id":"pmid:22404321","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22404321","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1476-5381.2012.01942.x","doi":"https://doi.org/10.1111/j.1476-5381.2012.01942.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.2012.01942.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.2012.01942.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8560000061988831}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7160619278","display_name":null,"funder_award_id":"IDI-20110577","funder_id":"https://openalex.org/F4320321043","funder_display_name":"Centro para el Desarrollo Tecnol\u00f3gico Industrial"}],"funders":[{"id":"https://openalex.org/F4320321043","display_name":"Centro para el Desarrollo Tecnol\u00f3gico Industrial","ror":"https://ror.org/0124x7055"},{"id":"https://openalex.org/F4320321992","display_name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Inova\u00e7\u00e3o","ror":"https://ror.org/050zdnc69"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2129373115.pdf","grobid_xml":"https://content.openalex.org/works/W2129373115.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W1493328574","https://openalex.org/W1561309798","https://openalex.org/W1574849955","https://openalex.org/W1664345731","https://openalex.org/W1758779245","https://openalex.org/W1916800927","https://openalex.org/W1964031071","https://openalex.org/W1975625572","https://openalex.org/W1978896524","https://openalex.org/W1988059170","https://openalex.org/W1993697980","https://openalex.org/W1994747123","https://openalex.org/W1995552213","https://openalex.org/W1996167692","https://openalex.org/W2000941955","https://openalex.org/W2016640476","https://openalex.org/W2031242571","https://openalex.org/W2038324519","https://openalex.org/W2045311068","https://openalex.org/W2049039867","https://openalex.org/W2050750242","https://openalex.org/W2051533639","https://openalex.org/W2060356177","https://openalex.org/W2065558719","https://openalex.org/W2065600453","https://openalex.org/W2066069377","https://openalex.org/W2066482395","https://openalex.org/W2070393781","https://openalex.org/W2103001937","https://openalex.org/W2114403556","https://openalex.org/W2123212921","https://openalex.org/W2131087015","https://openalex.org/W2155524482","https://openalex.org/W2158988264","https://openalex.org/W2161463814","https://openalex.org/W2166990751","https://openalex.org/W2170509135","https://openalex.org/W2231534981","https://openalex.org/W2234437665","https://openalex.org/W2274538329","https://openalex.org/W2335147441","https://openalex.org/W4406057286"],"related_works":["https://openalex.org/W2595144937","https://openalex.org/W2287944910","https://openalex.org/W2593075885","https://openalex.org/W1968514708","https://openalex.org/W2122203261","https://openalex.org/W2317715564","https://openalex.org/W1719312516","https://openalex.org/W2070393781","https://openalex.org/W2144782009","https://openalex.org/W2195682392"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1,211],"PURPOSE:":[2],"The":[3,68],"sigma-1":[4],"(\u03c3(1)":[5],")":[6],"receptor":[7,40,53,75,120,221,235],"is":[8,21,63],"a":[9,72,186,223],"ligand-regulated":[10],"molecular":[11],"chaperone":[12],"that":[13,51,192],"has":[14],"been":[15],"involved":[16],"in":[17,57,96,99,104,109,157,202],"pain,":[18],"but":[19],"there":[20],"limited":[22],"understanding":[23],"of":[24,38,71,89,92,151,154,180,195,225],"the":[25,33,49,87,158,164,171,199,219],"actions":[26],"associated":[27],"with":[28,163],"its":[29],"pharmacological":[30,36,44,69,90,193],"modulation.":[31],"Indeed,":[32],"selectivity":[34],"and":[35,48,102,113,137,142,173,229,232],"properties":[37,70],"\u03c3(1)":[39,52,74,93,119,155,196,220,234],"ligands":[41],"used":[42,84],"as":[43,222,237],"tools":[45],"are":[46],"unclear":[47],"demonstration":[50],"antagonists":[54,236],"have":[55],"efficacy":[56],"reversing":[58],"central":[59],"sensitization-related":[60],"pain":[61,230],"sensitivity":[62],"still":[64],"missing.":[65],"EXPERIMENTAL":[66],"APPROACH:":[67],"novel":[73,239],"antagonist":[76],"(S1RA)":[77],"were":[78,122,145],"first":[79],"characterized.":[80],"S1RA":[81,181],"was":[82,160],"then":[83],"to":[85,124,170,182,216],"investigate":[86],"effect":[88,175],"antagonism":[91,194],"receptors":[94,156,197],"on":[95,103],"vivo":[97,116],"nociception":[98,131],"sensitizing":[100],"conditions":[101],"vitro":[105],"spinal":[106,203,227],"cord":[107],"sensitization":[108,228],"mice.":[110,184],"Drug":[111],"levels":[112],"autoradiographic,":[114],"ex":[115],"binding":[117],"for":[118,241],"occupancy":[121],"measured":[123],"substantiate":[125],"behavioural":[126],"data.":[127],"KEY":[128],"RESULTS:":[129],"Formalin-induced":[130],"(both":[132],"phases),":[133],"capsaicin-induced":[134],"mechanical":[135,141],"hypersensitivity":[136,144],"sciatic":[138],"nerve":[139],"injury-induced":[140],"thermal":[143],"dose-dependently":[146],"inhibited":[147],"by":[148,206],"systemic":[149],"administration":[150,179],"S1RA.":[152],"Occupancy":[153],"CNS":[159],"significantly":[161],"correlated":[162],"antinociceptive":[165],"effects.":[166],"No":[167],"pharmacodynamic":[168],"tolerance":[169],"antiallodynic":[172],"antihyperalgesic":[174],"developed":[176],"following":[177],"repeated":[178],"nerve-injured":[183],"As":[185],"mechanistic":[187],"correlate,":[188],"electrophysiological":[189],"recordings":[190],"demonstrated":[191],"attenuated":[198],"wind-up":[200],"responses":[201],"cords":[204],"sensitized":[205],"repetitive":[207],"nociceptive":[208],"stimulation.":[209],"CONCLUSIONS":[210],"IMPLICATIONS:":[212],"These":[213],"findings":[214],"contribute":[215],"evidence":[217],"identifying":[218],"modulator":[224],"activity-induced":[226],"hypersensitivity,":[231],"suggest":[233],"potential":[238],"treatments":[240],"neuropathic":[242],"pain.":[243]},"counts_by_year":[{"year":2026,"cited_by_count":10},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":24},{"year":2019,"cited_by_count":16},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":18},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":16},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}